Statement Of Financial Position [Abstract]

ABIONYX Pharma - Filing #2816648

Concept	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	—	—	340,000 EUR	—	—	—	—	—	—	—	—	—	—	91,000 EUR	—	—	—	—	—	—
Goodwill	—	—	5 377 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	—	—	7 935 EUR	—	—	—	—	—	—	—	—	—	—	9 154 EUR	—	—	—	—	—	—
Assets	—	—	21 832 EUR	—	—	—	—	—	—	—	—	—	—	10 288 EUR	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	—	1 396 EUR	—	—	—	—	—	—	—	—	—	—	1 232 EUR	—	—	—	—	—	—
Share premium	—	—	179 214 EUR	—	—	—	—	—	—	—	—	—	—	170 322 EUR	—	—	—	—	—	—
Equity	201,000 EUR	169 829 EUR	10 677 EUR	10,000 EUR	179 214 EUR	87,000 EUR	1 396 EUR	1 232 EUR	5,000 EUR	136,000 EUR	39,000 EUR	164 822 EUR	170 322 EUR	6 629 EUR	110,000 EUR	163 034 EUR	1 097 EUR	6 666 EUR	168 621 EUR	92,000 EUR
Liabilities [abstract]
Provisions [abstract]
Provisions for employee benefits	—	—	504,000 EUR	—	—	—	—	—	—	—	—	—	—	61,000 EUR	—	—	—	—	—	—
Equity and liabilities	—	—	21 832 EUR	—	—	—	—	—	—	—	—	—	—	10 288 EUR	—	—	—	—	—	—